| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer (NCT05361174) | Iovance Biotherapeutics, Inc. | 2022-07-20 |
| Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC (NCT05157542) | Juan LI, MD | 2021-06-10 |
| A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC) (NCT04325763) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-05-27 |
| Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC (NCT04304638) | Chinese Academy of Medical Sciences | 2020-03-01 |
| Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia" (NCT05157503) | Autonomous Non-Profit Organization National Society of Onco-Pulmonologists | 2020-01-10 |
| A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer (NCT04181372) | The First Affiliated Hospital of Guangzhou Medical University | 2019-12-01 |
| Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy (NCT04085250) | Sun Yat-sen University | 2019-11-28 |
| Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer (NCT03871153) | Greg Durm, MD | 2019-08-02 |
| Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung (NCT03589547) | Brown University | 2019-05-13 |
| Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC (NCT04984148) | Guangdong Provincial People's Hospital | 2019-02-01 |
| Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC (NCT03822351) | MedImmune LLC | 2018-12-19 |
| Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC (NCT03742687) | Danish Lung Cancer Group | 2018-11-22 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
| Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT03048500) | Northwestern University | 2017-07-12 |
| Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 (NCT03049618) | University of Southern California | 2017-03-10 |
| Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer. (NCT05331833) | Jianguo Sun | 2016-08-01 |
| Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial (NCT03077854) | National Taiwan University Hospital | 2016-06-01 |
| MRI Optimization Study in Stage III NSCLC (NCT02076282) | UMC Utrecht | 2014-03-01 |
| Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens (NCT01948141) | Roswell Park Cancer Institute | 2014-01-30 |
| Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC (NCT01733589) | Zhejiang Cancer Hospital | 2012-11-01 |
| Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer (NCT01576796) | Centre Henri Becquerel | 2012-03-01 |
| Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC) (NCT01336543) | Syed Jafri | 2011-03-01 |
| Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) (NCT01102231) | Intergroupe Francophone de Cancerologie Thoracique | 2010-03-01 |
| Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer (NCT00938418) | National University Hospital, Singapore | 2009-07-01 |
| Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC (NCT01282437) | Maastricht Radiation Oncology | 2009-01-01 |
| Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer (NCT00019006) | National Cancer Institute (NCI) | 1995-03-01 |